zepbound eli lilly news

News

Eli Lilly, GLP-1

GLP-1 Pill From Eli Lilly Leads to Weight Loss and May Be Available Next Year

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Wired · 2d

Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.

Bloomberg on MSN · 2d

Lilly’s Experimental Obesity Pill Holds Up to Scrutiny in Trial

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s competition with Novo Nordisk A/S.

Free Malaysia Today on MSN · 2d

Chinese biotech showcases challenger to Eli Lilly’s obesity drug

Hangzhou Sciwind Biosciences claims its drug ecnoglutide delivers over 15% weight loss at highest dose after 48 weeks.

Seeking Alpha on MSN · 2d

Eli Lilly posts detailed late-stage trial data for oral weight loss drug orforglipron

Eli Lilly (NYSE:LLY) on Saturday announced detailed data from its ACHIEVE-1 Phase 3 trial, which reached the main goal for its oral weight loss therapy, orforglipron, in patients with type 2 diabetes early this year.

Stocktwits on MSN18h

Watch Out, Novo Nordisk & Eli Lilly: Chinese Biotech Steps Into the Ring To Take On Global Weight-Loss Leaders

Chinese biotech firm Hangzhou Sciwind Biosciences is stepping into the high-stakes global obesity drug race, with its ...

Clinical Trials Arena on MSN7h

Eli Lilly seeks green light for weekly insulin after strong trial results

Eli Lilly is looking to approach regulators for approval of its once-weekly insulin for type 2 diabetes (T2D) after it proved ...

Fierce Pharma7d

Eli Lilly adds high-dose Zepbound options to lineup of cheaper vials available on self-pay website

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

KYMA7d

Eli Lilly announces price cut for Zepbound

Eli Lilly is reducing the price of the highest doses of its popular drug Zepbound for folks who aren't using insurance.

BioSpace7h

Lilly Takes Victory Lap on Oral Weight Loss Drug as Analysts Spot Safety Crack

While Eli Lilly brushed off concerns about gastrointestinal side effects for oral weight loss candidate orforglipron, ...

Fierce Pharma9h

Diabetes and obesity boom will propel Lilly, Novo to front of pharma sales pack by 2030: Evaluate

Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...

STAT1d

Novo Nordisk’s amylin obesity drug keeps performing like Zepbound

Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new ...

PharmExec7d

Lilly Launches Full Zepbound Dose Access for Obesity Through LillyDirect Self-Pay Program

Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...

Indianapolis Business Journal6h

Lilly drug saves muscle when added to Wegovy weight-loss shot

The combination offers a potential solution to one of the key problems that’s emerged with popular obesity shots.

13don MSN

Lilly Pacts Prohibit Telehealth Sales of Copycat Zepbound

Eli Lilly & Co. will only work with telehealth firms that agree to stop selling copycat versions of weight-loss drugs, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results